VC Firm Dimension Raises $500 Million to Bet on AI and Medicine
Tech advancements will herald “generational shift” in health science, firm says.
This article is for subscribers only.
Dimension Capital, a venture firm targeting life sciences and technology startups, has raised $500 million just two years after debuting its first fund.
The New York-based firm aims to tap into trends such as the growth of artificial intelligence and the rise of new ways to develop medicine — particularly the use of technology in the search for new drugs.